CHADDS FORD, Pa., Dec. 30 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals today announced that it will present at the J.P. Morgan 28th Annual Healthcare Conference on Wednesday, Jan. 13, 2010, at 10:00 a.m. PST. David Holveck, president and chief executive officer of Endo, will review the company’s products and development programs.
About Endo
CONTACT: Investors/Media, Blaine Davis, +1-610-459-7158, Media, Kevin
Wiggins, +1-610-459-7281, Investors, Jonathan Neely, +1-610-459-6645
Web site: http://www.endo.com/
